National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Gestational Trophoblastic Tumors Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 12/05/2007



Purpose of This PDQ Summary






General Information






Cellular Classification






Stage Information






Treatment Option Overview






Hydatidiform Mole






Placental-Site Gestational Trophoblastic Tumors






Nonmetastatic Gestational Trophoblastic Tumors






Good-Prognosis Metastatic Gestational Trophoblastic Tumors






Poor-Prognosis Metastatic Gestational Trophoblastic Tumors






Recurrent Gestational Trophoblastic Tumors






Get More Information From NCI






Changes to This Summary (12/05/2007)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Cellular Classification

Gestational trophoblastic tumors may be classified as follows:[1]

  • Hydatidiform mole.
  • Invasive mole (chorioadenoma destruens).
  • Choriocarcinoma.
  • Placental-site trophoblastic tumor.

Hydatidiform mole

Hydatidiform mole is defined as products of conception that lack an intact fetus and show gross cyst-like swellings of the chorionic villi caused by an accumulation of fluid. There is disintegration and loss of blood vessels in the villous core.

Invasive mole

Invasive mole (chorioadenoma destruens) is a locally invasive, rarely metastatic lesion characterized microscopically by trophoblastic invasion of the myometrium with identifiable villous structures. Microscopically, this lesion is characterized by hyperplasia of cytotrophoblastic and syncytial elements and persistence of villous structures.

Choriocarcinoma

Choriocarcinoma is a malignant tumor of the trophoblastic epithelium. Uterine muscle and blood vessels are invaded with areas of hemorrhage and necrosis. Columns and sheets of trophoblastic tissue invade normal tissues and spread to distant sites, the most common of which are lungs, brain, liver, pelvis, vagina, spleen, intestines, and kidney.

Placental-site trophoblastic tumor

Placental-site trophoblastic disease is an extremely rare tumor arising from the placental implantation site and resembles an exaggerated form of syncytial endometritis. Trophoblastic cells infiltrate the myometrium, and there is vascular invasion. Human placental lactogen is present in the tumor cells, while immunoperoxidase staining for human chorionic gonadotropin (hCG) is positive in only scattered cells, and serum hCG is relatively low.[1]

References

  1. Lurain JR: Gestational trophoblastic tumors. Semin Surg Oncol 6 (6): 347-53, 1990.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov